Subscribe to Newsletter

April 2023 Issue of The Medicine Maker

Our April issue celebrates the 2023 Power List and Company of the Year Awards! The Power List features thirty inspirational individuals and Company of the Year showcases 8 organizations at the top of their game. This issue also includes articles on AI’s potential in drug discovery; optimizing downstream processes; improving antibody manufacturing with CRISPR technology; and industry trends affecting drug delivery. We wrap the issue up with an exclusive interview featuring Carl June.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Login
Forgot your password?
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

 Business & Regulation Profession

The Power List 2023 Is Live

| Stephanie Vine

The wait is over. Our annual celebration of the pharma industry’s most influential individuals has returned!
Discovery & Development Ingredients

The Grand Winner

| Stephanie Vine

Voting for The Medicine Maker Innovation Awards has ended and we are delighted to announce our grand winner.
Discovery & Development Drug Discovery

How Data Sharing Can Upgrade AI for Pharma

| Robin Röhm | 5 min read

AI for drug discovery has enormous potential; to unlock it, we need to reset our mindset
Business & Regulation Business Practice

Between Two Worlds: Doing Business as a Cell and Gene Academic

| Stuart Curbishley | 6 min read

Pharma depends on academia, but that relationship can become better… and more fluid

Manufacture Bioprocessing - Upstream & Downstream

Welcome to the CRISPR Powerhouse

| Eric Rhodes | 4 min read

Why 2023 is the year that antibody manufacturers should embrace CRISPR gene editing.
Manufacture Bioprocessing - Upstream & Downstream

Top Tips to Optimize Downstream Processes

| Nandu Deorkar, Jungmin Oh, Pranav Vengsarkar, Jonathan Fura | 6 min read

From resins to buffers to single-use technologies – there are many opportunities to improve downstream processes.

Other issues of 2023